in conclusion , antibody to platelet gpiib/iiia receptors : ( 1 ) prevented thrombotic lcca occlusion , ( 2 ) inhibited ex vivo platelet aggregation , ( 3 ) minimized platelet deposition on injured vascular endothelium and within formed thrombi , and ( 4 ) stabilized cbf during 5 h of continuous direct current induced intimal injury of the lcca .
C0016011
gpiib/iiia receptors
C0032176
platelet aggregation